$RNA

Avidity Biosciences Inc

$RNA

Avidity Biosciences Inc

Past 12mo:12mentions1voices

All voices4 calls since Aug 2025show all

Loading price chart…

Frequently asked

Who mentions $RNA most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $RNA most — 12 mentions in the past 12 months.

When was $RNA first mentioned on Surfaced?

The earliest tracked mention of $RNA in the Surfaced archive was on Aug 6, 2025.

How many voices track $RNA?

1 FinTwit voice has mentioned $RNA 12 times in the past 12 months.

What kind of voices mention $RNA most?

$RNA is mentioned most by Biotech voices on Surfaced.

Recent calls

4 calls

@adamfeuersteinOct 26, 2025 · 5:44 PM

Novartis $NVS to buy RNA-focused Avidity $RNA in $12B deal ... the Swiss pharma also framed the deal as one that would give it a new platform, with Avidity designing a class of drugs focused on delivering RNA to muscle, what it calls antibody oligonucleotide conjugates, or AOCs. Novartis said the programs from San Diego-based Avidity would complement its existing neuroscience strategy. https://t.co/R9mIfBDhbw via @DrewQJoseph

Open on X

@adamfeuersteinOct 13, 2025 · 1:21 PM

$RNA - del-zota BLA submission pushed back to Q1 '26 from Q4 '25... "to ensure the FDA receives additional data to support the chemistry, manufacturing, and controls (CMC) package at time of submission." https://t.co/aLbJxhmnFU

Open on X

@adamfeuersteinSep 3, 2025 · 7:08 PM

$RNA at Cantor today, on acquisition chatter... Question – But there has been rumors of acquisition interest in your company. What, if anything, do you want to share about that? Answer – Yeah. You know, look, I would say we're now entering into an era, another Taylor Swift pun. We're now entering into an era where we're probably going to have a lot of rumors about us and around the interest in Avidity. Well, we have three drugs that we're looking to launch in a 12-month period. Two of those drugs, we believe are multibillion-dollar indications. So extremely valuable. And I expect here, there's going to be lots of rumors about us. What I will say is for us as a team, we are 100% focused on delivering to patients and getting our drugs to patients as quickly as possible, because we believe, yeah, as does the patient community, the clinical community, and I think starting the investor community now as well and I know you're a big supporter that we have the potential to make a profound impact in tens of thousands of people's lives, and that's what we're focused on. h/t Alphasense

Open on X

@adamfeuersteinAug 6, 2025 · 3:20 PM

Novartis $NVS reportedly considering acquisition of Avidity Biosciences $RNA - Financial Times.

Open on X